Cyprus vs Japan: Cause of death, by non-communicable diseases, ages 15-59, male
Cyprus
72.2%
in 2021
Japan
72.4%
in 2021
Cyprus rank
24th
Japan rank
21st
Cause of death, by non-communicable diseases, ages 15-59, male over time
- Cyprus
- Japan
How they compare
Japan currently reports 72.4% against 72.2% in Cyprus, a difference of 0.2%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Cyprus ahead.
Cyprus ranks 24th and Japan ranks 21st of 185 countries.
Cyprus has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cyprus | Japan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 68.9% | 67.0% | 1.9% | Cyprus |
| 2010s | 76.8% | 70.4% | 6.4% | Cyprus |
| 2020s | 75.1% | 73.0% | 2.1% | Cyprus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, Cyprus or Japan?
- Japan, at 72.4% against 72.2% in Cyprus as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between Cyprus and Japan?
- 0.2%, with Japan ahead.
- How many years of comparable data are there for Cyprus and Japan?
- 6 years are reported by both, from 2000 to 2021.
- How do Cyprus and Japan rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- Cyprus ranks 24th and Japan ranks 21st of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.